Syngene International Ltd.

NSE: SYNGENE | BSE: 539268 | ISIN: INE398R01022 | Industry: Pharmaceuticals
| Slowing Down Stock
404.6500 11.55 (2.94%)
NSE Apr 10, 2026 15:31 PM
Volume: 2.6M
 

404.65
2.94%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 11% YoY to | 335 crore (I-direct estimate: | 320 crore) due to strong performance in development & manufacturing services and sustained growth in dedicated R&D; centres Gross margins improved 204 bps YoY to 76.1% but EBITDA margins declined 99 bps to 33.9% YoY (I-direct estimate: 33%) mainly due to higher employee expenses. EBITDA in value terms grew 7.5% YoY to | 114 crore (I-direct estimate: | 106 crore)...
Syngene Intl has lost -36.63% in the last 6 Months
More from Syngene International Ltd.
Recommended